Filling the need for trusted information on national health issues…

The cost of prescription drugs remains a hot-button issue for consumers and policymakers. The vast majority of the public views drug prices as unreasonable, and one in four people taking prescription drugs report difficulty affording their medication. Recently, the Trump Administration, Congress and state and federal policy makers have focused renewed attention on potential actions to address drug costs, including regulatory and legislative changes that affect Medicare, Medicaid and private insurance.  This collection includes KFF research, analysis and public opinion data, as well as Kaiser Health News’ journalism, related to prescription drugs and their costs.
  • Your Selections:

Refine Results

date

Topics

Tags

Content Type

Program

2013 Employer Health Benefits Survey

This annual Employer Health Benefits Survey (EHBS) provides a detailed look at trends in employer-sponsored health coverage, including premiums, employee contributions, cost-sharing provisions, and other relevant information. The 2013 EHBS survey finds average family health premiums rose 4 percent in 2013, relatively modest growth by historical standards.

Understanding The Effects of The Medicare Part D Coverage Gap in 2008 and 2009

This Kaiser Family Foundation study examines how the coverage gap in Medicare’s drug benefit known as the “doughnut hole” affects Medicare beneficiaries and their prescribing patterns. Based on actual claims data from 2008 and 2009, before the 2010 health reform law began to close the gap, the study finds that…

A Profile of African Americans, Latinos, and Whites with Medicare:

This chartpack highlights demographic data about African Americans, Hispanics and whites with Medicare to highlight potential implications for outreach efforts under the new Medicare drug benefit. The information is being used in a series of November 2005 briefings at the start of the first open-enrollment period for the new benefit.…

Transitions 2006

On January 1, 2006, the six million Americans who are covered by both Medicare and Medicaid saw a change in how their prescription drugs are covered. The dual eligible population was transitioned from Medicaid into the Medicare prescription drug benefit. As a group, these beneficiaries are poorer and sicker than…

Transitions 2005

Transitions is a video that explores some of the issues and challenges “dual eligibles” may face during the transition from Medicaid drug coverage to Medicare. To download the video, right-click here and select “Save as…”

Paying for Prescribed Drugs in Medicaid: Current Policy and Upcoming Changes

The federal government has proposed new rules that aim to make Medicaid outpatient drug reimbursement policies more closely match the cost of obtaining and filling prescriptions. However, the change in policy may have varying effects on reimbursement, depending on the state’s current approach and the type of drug in question. This paper explains current Medicaid pharmacy reimbursement methodology and examines the potential effect of the proposed rule changes.

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.